EverSource Wealth Advisors LLC Purchases 518 Shares of The Cooper Companies, Inc. (NASDAQ:COO)

EverSource Wealth Advisors LLC increased its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 9.0% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 6,297 shares of the medical device company’s stock after purchasing an additional 518 shares during the quarter. EverSource Wealth Advisors LLC’s holdings in Cooper Companies were worth $579,000 at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Ashton Thomas Securities LLC bought a new stake in shares of Cooper Companies in the 3rd quarter worth approximately $25,000. Byrne Asset Management LLC bought a new stake in shares of Cooper Companies in the 4th quarter worth approximately $33,000. OFI Invest Asset Management bought a new stake in shares of Cooper Companies in the 4th quarter worth approximately $34,000. Covestor Ltd raised its holdings in shares of Cooper Companies by 144.9% in the 3rd quarter. Covestor Ltd now owns 338 shares of the medical device company’s stock worth $37,000 after purchasing an additional 200 shares during the period. Finally, Brown Brothers Harriman & Co. raised its holdings in shares of Cooper Companies by 191.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 419 shares of the medical device company’s stock worth $46,000 after purchasing an additional 275 shares during the period. Institutional investors own 24.39% of the company’s stock.

Analysts Set New Price Targets

COO has been the topic of a number of research reports. Morgan Stanley lowered their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a report on Friday, December 6th. Stifel Nicolaus lowered their target price on shares of Cooper Companies from $115.00 to $105.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Citigroup lowered their target price on shares of Cooper Companies from $115.00 to $110.00 and set a “buy” rating on the stock in a report on Friday, March 7th. Wells Fargo & Company boosted their target price on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a report on Friday, December 6th. Finally, Robert W. Baird lowered their target price on shares of Cooper Companies from $117.00 to $107.00 and set an “outperform” rating on the stock in a report on Friday, March 7th. Three equities research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $111.89.

Cooper Companies Stock Up 4.5 %

COO opened at $81.22 on Friday. The company has a fifty day moving average price of $91.20 and a 200-day moving average price of $98.86. The firm has a market capitalization of $16.21 billion, a P/E ratio of 41.65, a price-to-earnings-growth ratio of 2.25 and a beta of 1.02. The company has a debt-to-equity ratio of 0.32, a current ratio of 1.91 and a quick ratio of 1.12. The Cooper Companies, Inc. has a one year low of $77.05 and a one year high of $112.38.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts’ consensus estimates of $0.92. The firm had revenue of $964.70 million during the quarter, compared to analyst estimates of $981.25 million. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. Equities research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current fiscal year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.